Venlafaxine hydrochloride and Tendonitis exacerbated - a phase IV clinical study of FDA data

Summary:

Tendonitis exacerbated is reported as a side effect among people who take Venlafaxine hydrochloride (venlafaxine hydrochloride), especially for people who are female, 50-59 old, have been taking the drug for 6 - 12 months also take Allegra, and have Osteoporosis.

The phase IV clinical study analyzes which people have Tendonitis exacerbated when taking Venlafaxine hydrochloride. It is created by eHealthMe based on reports of 15,424 people who have side effects when taking Venlafaxine hydrochloride from the FDA, and is updated regularly.

What is Venlafaxine hydrochloride?

Venlafaxine hydrochloride has active ingredients of venlafaxine hydrochloride. It is often used in depression. eHealthMe is studying from 17,916 Venlafaxine hydrochloride users. Check the latest studies of Venlafaxine hydrochloride.

What is Tendonitis exacerbated?

Tendonitis exacerbated (a condition that causes pain and swelling of tendons) is found to be associated with 943 drugs and 505 conditions by eHealthMe. Check the latest studies of Tendonitis exacerbated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 24, 2026

15,424 people reported to have side effects when taking Venlafaxine hydrochloride.
Among them, 26 people (0.17%) have Tendonitis exacerbated.

Could Venlafaxine hydrochloride cause Tendonitis exacerbated?

Among these 26 people:

How long have people been on Venlafaxine hydrochloride when they have Tendonitis exacerbated? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 100 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Tendonitis exacerbated when taking Venlafaxine hydrochloride? *

  • female: 76.92 %
  • male: 23.08 %

What is the age of people who have Tendonitis exacerbated when taking Venlafaxine hydrochloride? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 8.33 %
  • 40-49: 0.0 %
  • 50-59: 62.5 %
  • 60+: 29.17 %

What are other drugs people take besides Venlafaxine hydrochloride? *

  1. Allegra: 10 people, 38.46%
  2. Prempro: 9 people, 34.62%
  3. Alendronate Sodium: 9 people, 34.62%
  4. Rosuvastatin Calcium: 9 people, 34.62%
  5. Fosamax: 9 people, 34.62%
  6. Omega-3 Marine Triglycerides: 9 people, 34.62%
  7. Dalfampridine: 4 people, 15.38%
  8. Ocrevus: 4 people, 15.38%
  9. Baclofen: 4 people, 15.38%
  10. Amlodipine Besylate: 4 people, 15.38%

What are other side effects people have besides Tendonitis exacerbated? *

  1. Joint Pain: 21 people, 80.77%
  2. Weakness: 18 people, 69.23%
  3. Pain: 16 people, 61.54%
  4. Memory Loss: 16 people, 61.54%
  5. Fatigue (feeling of tiredness): 16 people, 61.54%
  6. Gait Disturbance: 16 people, 61.54%
  7. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 14 people, 53.85%
  8. Fall: 14 people, 53.85%
  9. Mobility Decreased (ability to move is reduced): 13 people, 50.00%
  10. Muscle Aches (muscle pain): 11 people, 42.31%

What are the existing conditions these people have? *

  1. Osteoporosis (bones weak and more likely to break): 9 people, 34.62%
  2. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 4 people, 15.38%
  3. Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 4 people, 15.38%
  4. Primary Progressive Multiple Sclerosis (primary progressive inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 4 people, 15.38%
  5. Type 2 Diabetes: 2 people, 7.69%
  6. Endometriosis (appearance of endometrial tissue outside the uterus and causing pelvic pain): 2 people, 7.69%
  7. Neuralgia (pain in one or more nerves): 2 people, 7.69%
  8. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 7.69%
  9. Psoriasis (immune-mediated disease that affects the skin): 2 people, 7.69%
  10. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Venlafaxine hydrochloride and have Tendonitis exacerbated?

- Check whether Tendonitis exacerbated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Venlafaxine hydrochloride:

Tendonitis exacerbated treatments and more:

How severe was Tendonitis exacerbated and when was it recovered:

Expand to all the drugs that have ingredients of venlafaxine hydrochloride:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Venlafaxine hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Tendonitis exacerbated:

Browse all the conditions that are associated with Tendonitis exacerbated:


How the study uses the data?

The study uses data from the FDA. It is based on venlafaxine hydrochloride (the active ingredients of Venlafaxine hydrochloride) and Venlafaxine hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: